How much is the Premature Ejaculation Treatment market?

The premature ejaculation treatment market size is estimated to grow at $$ 1527.7 mn in 2024. Read More

What is the growth rate of the Premature Ejaculation Treatment market?

The growth rate of the premature ejaculation treatment year-over-year is 8.6%. Read More

Which region held the largest market share in the Premature Ejaculation Treatment market?

North America is the region to held the largest market share with 45% growth. Read More

Who are the key players in the Premature Ejaculation Treatment market?

A. Menarini Industrie Farmaceutiche Riunite Srl, Absorption Pharmaceuticals LLC, Alembic Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., Aytu BioPharma Inc., Bayer AG, Eli Lilly and Co., Futura .... Read More

Which Segment has the largest market share in the Premature Ejaculation Treatment market?

Route Of Administration is the segment that has the largest market share in the market. Read More

Premature Ejaculation Treatment Market Analysis North America, Europe, Asia, Rest of World (ROW) - China, US, Italy, UK, Germany, India, Canada, Japan, Brazil, Saudi Arabia - Size and Forecast 2025-2029

Published: Dec 2024
Pages: 201
SKU: IRTNTR70413

Enjoy complimentary customisation on priority with our Enterprise License!

Premature Ejaculation Treatment Market Size 2025-2029

The premature ejaculation treatment market size is forecast to increase by USD 1.53 billion, at a CAGR of 8.6% between 2024 and 2029. The market is experiencing significant growth driven by several factors. One of the key factors is the high efficacy of off-label drugs in treating premature ejaculation, which has boosted their adoption. Additionally, the emergence of nanotechnology in treatment drugs is a notable trend shaping market dynamics. Nanotechnology offers potential benefits such as advanced drug delivery systems and reduced side effects, attracting attention from both manufacturers and consumers. However, despite these advancements, a major challenge facing the market is the side effects associated with some treatment drugs. These side effects, including potential cardiovascular issues and dizziness, may hinder the widespread adoption of such treatments, limiting overall market growth.

What will be the Size of the Market During the Forecast Period?

To learn more about the market report, Request Free Sample

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation

2.3 Factors of disruption
- Overview on factors of disruption

2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market

3.2 Market characteristics
- Market characteristics analysis

3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition

4.2 Market segment analysis
- Market segments

4.3 Market size 2024

4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Premature Ejaculation Treatment Market 2019 - 2023
- Historic Market Size - Data Table on Global Premature Ejaculation Treatment Market 2019 - 2023 ($ million)

5.2 Route of Administration segment analysis 2019 - 2023
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)

5.3 Drug Class segment analysis 2019 - 2023
- Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)

5.4 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)

5.5 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on Global Premature Ejaculation Treatment Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029

7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029

7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029

7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029

7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029

7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029

7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Route of Administration

8.1 Market segments
- Chart on Route of Administration - Market share 2024-2029 (%)
- Data Table on Route of Administration - Market share 2024-2029 (%)

8.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration

8.3 Oral - Market size and forecast 2024-2029
- Chart on Oral - Market size and forecast 2024-2029 ($ million)
- Data Table on Oral - Market size and forecast 2024-2029 ($ million)
- Chart on Oral - Year-over-year growth 2024-2029 (%)
- Data Table on Oral - Year-over-year growth 2024-2029 (%)

8.4 Topical - Market size and forecast 2024-2029
- Chart on Topical - Market size and forecast 2024-2029 ($ million)
- Data Table on Topical - Market size and forecast 2024-2029 ($ million)
- Chart on Topical - Year-over-year growth 2024-2029 (%)
- Data Table on Topical - Year-over-year growth 2024-2029 (%)

8.5 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)

9 Market Segmentation by Drug Class

9.1 Market segments
- Chart on Drug Class - Market share 2024-2029 (%)
- Data Table on Drug Class - Market share 2024-2029 (%)

9.2 Comparison by Drug Class
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class

9.3 SSRIs - Market size and forecast 2024-2029
- Chart on SSRIs - Market size and forecast 2024-2029 ($ million)
- Data Table on SSRIs - Market size and forecast 2024-2029 ($ million)
- Chart on SSRIs - Year-over-year growth 2024-2029 (%)
- Data Table on SSRIs - Year-over-year growth 2024-2029 (%)

9.4 PDE5 inhibitors - Market size and forecast 2024-2029
- Chart on PDE5 inhibitors - Market size and forecast 2024-2029 ($ million)
- Data Table on PDE5 inhibitors - Market size and forecast 2024-2029 ($ million)
- Chart on PDE5 inhibitors - Year-over-year growth 2024-2029 (%)
- Data Table on PDE5 inhibitors - Year-over-year growth 2024-2029 (%)

9.5 Amide anesthetics - Market size and forecast 2024-2029
- Chart on Amide anesthetics - Market size and forecast 2024-2029 ($ million)
- Data Table on Amide anesthetics - Market size and forecast 2024-2029 ($ million)
- Chart on Amide anesthetics - Year-over-year growth 2024-2029 (%)
- Data Table on Amide anesthetics - Year-over-year growth 2024-2029 (%)

9.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)

9.7 Market opportunity by Drug Class
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)

10 Customer Landscape

10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

11.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)

11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison

11.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)

11.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)

11.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)

11.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)

11.7 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)

11.8 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)

11.9 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)

11.10 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)

11.11 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)

11.12 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)

11.13 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)

11.14 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)

11.15 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)

11.16 Saudi Arabia - Market size and forecast 2024-2029
- Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)

11.17 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

12.1 Market drivers

12.2 Market challenges

12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

12.4 Market opportunities/restraints

13 Competitive Landscape

13.1 Overview

13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation

13.3 Landscape disruption
- Overview on factors of disruption

13.4 Industry risks
- Impact of key risks on business

14 Competitive Analysis

14.1 Companies profiled
- Companies covered

14.2 Company ranking index
- Company ranking index

14.3 Market positioning of companies
- Matrix on companies position and classification

14.4 A. Menarini Industrie Farmaceutiche Riunite Srl
- A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
- A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
- A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
- SWOT

14.5 Absorption Pharmaceuticals LLC
- Absorption Pharmaceuticals LLC - Overview
- Absorption Pharmaceuticals LLC - Product / Service
- Absorption Pharmaceuticals LLC - Key offerings
- SWOT

14.6 Alembic Pharmaceuticals Ltd.
- Alembic Pharmaceuticals Ltd. - Overview
- Alembic Pharmaceuticals Ltd. - Product / Service
- Alembic Pharmaceuticals Ltd. - Key offerings
- SWOT

14.7 Amneal Pharmaceuticals Inc.
- Amneal Pharmaceuticals Inc. - Overview
- Amneal Pharmaceuticals Inc. - Business segments
- Amneal Pharmaceuticals Inc. - Key news
- Amneal Pharmaceuticals Inc. - Key offerings
- Amneal Pharmaceuticals Inc. - Segment focus
- SWOT

14.8 Aytu BioPharma Inc.
- Aytu BioPharma Inc. - Overview
- Aytu BioPharma Inc. - Product / Service
- Aytu BioPharma Inc. - Key offerings
- SWOT

14.9 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT

14.10 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT

14.11 Futura Medical Plc
- Futura Medical Plc - Overview
- Futura Medical Plc - Product / Service
- Futura Medical Plc - Key offerings
- SWOT

14.12 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT

14.13 Johnson and Johnson Inc.
- Johnson and Johnson Inc. - Overview
- Johnson and Johnson Inc. - Business segments
- Johnson and Johnson Inc. - Key news
- Johnson and Johnson Inc. - Key offerings
- Johnson and Johnson Inc. - Segment focus
- SWOT

14.14 LloydsPharmacy
- LloydsPharmacy - Overview
- LloydsPharmacy - Product / Service
- LloydsPharmacy - Key offerings
- SWOT

14.15 NeuroHealing Pharmaceuticals Inc.
- NeuroHealing Pharmaceuticals Inc. - Overview
- NeuroHealing Pharmaceuticals Inc. - Product / Service
- NeuroHealing Pharmaceuticals Inc. - Key offerings
- SWOT

14.16 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT

14.17 Plethora Solutions Ltd.
- Plethora Solutions Ltd. - Overview
- Plethora Solutions Ltd. - Product / Service
- Plethora Solutions Ltd. - Key offerings
- SWOT

14.18 Veru Inc.
- Veru Inc. - Overview
- Veru Inc. - Business segments
- Veru Inc. - Key news
- Veru Inc. - Key offerings
- Veru Inc. - Segment focus
- SWOT

15 Appendix